In Migraine Nomigan DP Tablet is a combination of medicines that treat and prevent migraine headaches. It changes the electrical activity in the brain, blocks chemicals responsible for pain sensation and also blocks signals that cause nausea/vomiting associated with migraines. By preventing and reducing the frequency of migraine headaches, it can help you carry out your daily activities and have a better quality of life.
It is unsafe to consume alcohol with Nomigan DP Tablet.
Nomigan DP Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Nomigan DP Tablet during breastfeeding is not available. Please consult your doctor.
Nomigan DP Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Nomigan DP Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Nomigan DP Tablet may not be needed in these patients. Please consult your doctor.
Nomigan DP Tablet should be used with caution in patients with liver disease. Dose adjustment of Nomigan DP Tablet may be needed. Please consult your doctor. However, the use of Nomigan DP Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Nomigan DP Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Ultramark Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Solitaire Pharmacia Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Fox & Wolf Health Care || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Tidal Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Care Formulations || ₹14.5/tablet (25% cheaper)